Apimeds Pharmaceuticals US, Inc. Completes Initial Public Offering, Raising $13.5 Million for Clinical Development
12/5 23:20
Apimeds Pharmaceuticals closed its IPO, raising $13.5 million to fund clinical trials and general operational costs....
|
|
|
12/5 23:20
Apimeds Pharmaceuticals closed its IPO, raising $13.5 million to fund clinical trials and general operational costs....